Riovie Review

Is Riovie worth it?

What Riovie is selling, in one line, is low published compounded GLP-1 prices, injection or tablet, with B12 or glycine at no extra cost. It runs $149/month, toward the affordable end of the category, so cost isn't the reason to look elsewhere. Its standout is a needle-free oral option for people who would rather not inject.

It is LegitScript-certified. It also names the pharmacy that fills its prescriptions and charges no membership fee.

How much Riovie costs

Compounded semaglutide runs $115–$209/month depending on plan, the low end a 3-month plan rate, and compounded tirzepatide runs $195–$259/month depending on plan, the low end a 3-month plan rate.

That puts Riovie below the roughly $179 median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide), which is a cost advantage you can count on.

Sesame Care (about $149/month) is one of the closest alternatives to weigh Riovie against.

Medications: what Riovie prescribes

Riovie prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.

Riovie's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who Riovie is best for, and who should skip it

A good fit if you…

• are focused on the lowest ongoing monthly cost: $149/month is below the roughly $179 median we track across the category (each program's lowest listed ongoing monthly price).
• are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
• live anywhere in the US and want the certainty that your state is already covered.

Look elsewhere if you…

• specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
• need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

Riovie treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.

Bottom line

Riovie earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.